TipRanks
Go Ultimate55% OFF

Suven Pharmaceuticals Ltd. (COHANCE) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

COHANCE Analyst Ratings

Moderate Sell
1Ratings
0Buy0Hold1Sell
Based on 1 analysts giving stock ratings to Suven Pharmaceuticals Ltd. in the past 3 months

COHANCE Stock 12 Month Forecast

INR 350.00▼(-21.25% Downside)
Based on 1 Wall Street analysts offering 12 month price targets for Suven Pharmaceuticals Ltd. in the last 3 months. The average price target is INR 350.00 with a high forecast of INR 350.00 and a low forecast of INR 350.00. The average price target represents a -21.25% change from the last price of INR 444.45.
Highest Price TargetINR 350.00Average Price TargetINR 350.00Lowest Price TargetINR 350.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IN:COHANCE
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
JefferiesINR 300→INR 350sell-21.25%DownsideReiterated08/06/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Suven Pharmaceuticals Ltd.

3 Months
Alok Dalal
Alok DalalJefferies
Success Rate1/2 ratings generated profit
50%
Average Return
+0.35%

Copying Alok Dalal's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.35% per trade.

1 Year
Alok Dalal
Alok DalalJefferies
Success Rate1/2 ratings generated profit
50%
Average Return
-0.10%

Copying Alok Dalal's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.10% per trade.

2 Years
Alok Dalal
Alok DalalJefferies
Success Rate1/2 ratings generated profit
50%
Average Return
-0.10%

Copying Alok Dalal's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.10% per trade.

COHANCE Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for COHANCE
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold00000
Sell11111
Strong Sell00000
total11111

In the current month, COHANCE has received 0 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. COHANCE average Analyst price target in the past 3 months is 350.00.

COHANCE Financial Forecast

INR -2INR -1INR 0INR 1INR 2Q3 2026Q1 2027Q2 2027
HighINR 0.24
ConsensusINR -0.04
LowINR -0.30

COHANCE Earnings Forecast

Next quarter’s earnings estimate for COHANCE is -INR 0.04 with a range of -INR 0.30 to INR 0.24. The previous quarter’s EPS was -INR 0.60. COHANCE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year COHANCE has Performed in-line its overall industry.

INR 4.2BINR 4.7BINR 5.2BINR 5.7BINR 6.2BQ3 2026Q1 2027Q2 2027
HighINR 4.91B
ConsensusINR 4.8B
LowINR 4.6B

COHANCE Sales Forecast

Next quarter’s sales forecast for COHANCE is INR 4.80B with a range of INR 4.60B to INR 4.91B. The previous quarter’s sales results were INR 4.22B. COHANCE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year COHANCE has Performed in-line its overall industry.

COHANCE Stock Forecast FAQ

What is IN:COHANCE’s average 12-month price target, according to analysts?
Based on analyst ratings, Suven Pharmaceuticals Ltd.’s 12-month average price target is ₹350.00.
What is IN:COHANCE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:COHANCE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Suven Pharmaceuticals Ltd. a Buy, Sell or Hold?
Suven Pharmaceuticals Ltd. has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 1 sell ratings.
What is Suven Pharmaceuticals Ltd.’s share price target?
The average share price target for Suven Pharmaceuticals Ltd. is ₹350.00. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ₹350.00, and the lowest forecast is ₹350.00. The average share price target represents a 21.25% decrease from the current price of ₹444.45.
What do analysts say about Suven Pharmaceuticals Ltd.?
Suven Pharmaceuticals Ltd.’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Suven Pharmaceuticals Ltd.?
To buy shares of IN:COHANCE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.